JEFFREY LINDABERRY: Open Payments
NPI 1164414546 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 55 payments from 18 companies in 2025. Trend: 2023 $1,535 · 2024 $1,896 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $175 |
| Supernus Pharmaceuticals, Inc. | 5 | $165 |
| Novo Nordisk Inc | 6 | $130 |
| ABBVIE INC. | 5 | $80 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Exact Sciences Corporation | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: Kerendia, Qelbree, CAPLYTA, TRELEGY ELLIPTA, Cologuard Collection Kit, Auvelity, UBRELVY, JARDIANCE.
Industry payments across SC — which companies pay providers there.
